Delivery Order SPE2DB24D2205-SPE2DB24FDVXP

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $56,667.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a completion date of December 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a $12,592.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, and has an ultimate completion date of March 3, 2025. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $61,655.00 fixed-price contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a completion date of January 25, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a $12,722.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,254,347 units of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The contract has an ultimate completion date of July 26, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a for-profit organization, is the prime...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The $1,826.55 contract is for the supply of 1 vial of the MENVEO A-C-Y-W-135 diphtheria conjugate vaccine in 0.5 mL doses. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical...
This $31,029.48 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a completion date of June 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a $30,442.50 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines and has a completion date of June 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a ceiling value of $31,029.48 and a completion date of June 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,346.65 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of December 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1 vial of the MENVEO A-C-Y-W-135-DIP vaccine. The contract has a ceiling value of $97,155.42 and a performance period ending on May 12, 2023. This order is placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVXP
    Delivery Order

This is a $45,663.75 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a period of performance through June 24, 2024.

The contract was awarded under an Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:10 AM